Pfizer (PFE) Down 3.1% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 08/27/20
Pfizer Is Out, Honeywell Is In: Should The Dow Jones Shake-Up Change Your Investing Strategy?The Motley Fool • 08/27/20
Dow Jones: The Real Reason Exxon, Pfizer, and Raytheon Are Being Kicked Out of the Iconic IndexThe Motley Fool • 08/27/20
Pfizer Says It Has Over 50% Enrollment for Coronavirus Vaccine Candidate TrialThe Motley Fool • 08/26/20
Another Reason to Believe Pfizer Could Have a Coronavirus Vaccine Ready in OctoberThe Motley Fool • 08/26/20
AstraZeneca, Novavax, Pfizer, Others Lobby EU For Legal Protection Against COVID-19 Vaccine Liabilities: FTBenzinga • 08/26/20
Salesforce, Amgen and Honeywell higher premarket on Dow-joining news; Exxon, Pfizer and Raytheon move lowerMarket Watch • 08/25/20
Pfizer and BioNTech's Coronavirus Vaccine Candidate Produces Antibodies in People Up to 85 Years OldThe Motley Fool • 08/21/20
The Data Just Keeps Getting Better for Pfizer and BioNTech’s COVID-19 Vaccine24/7 Wall Street • 08/21/20